CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 8-K Event Other events
- 4 Open-market sale Director sold 11,570 shares at an average $5.29 ($61,261)
- 8-K Event Other events
- 4 Open-market buy Director bought 2,470 shares at an average $5.47 ($13,500)
- 4 Open-market buy Director bought 2,280 shares at an average $5.47 ($12,461)
- 4 Open-market sale Director sold 10,915 shares at an average $5.09 ($55,550)
- 4 Open-market buy Chairman and CEO bought 2,280 shares at an average $5.47 ($12,461)
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 9,446 shares at an average $5.16 ($48,716)
- 8-K Event Other events
- 8-K Event Other events
- 4 Shares withheld for taxes SVP and Chief Development Off. gave up 1,850 shares (to pay taxes)
- 4 Open-market sale Director sold 3,100 shares at an average $5.16 ($16,003)
- 8-K Event Other events
- 4 Open-market sale Director sold 6,309 shares at an average $5.46 ($34,432)
- 4 Open-market sale Director sold 6,290 shares at an average $5.92 ($37,258)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 4,872 shares at an average $5.82 ($28,369)
- 4 Open-market buy Director bought 1,820 shares at an average $6.22 ($11,323)
Page 24 of 52 · 1,039 filings